| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J Kreuter, D Shamenkov, V Petrov, P Ramge, K Cychutek, C Koch-Brandt, ... Journal of drug targeting 10 (4), 317-325, 2002 | 911 | 2002 |
| Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) J Kreuter, RN Alyautdin, DA Kharkevich, AA Ivanov Brain research 674 (1), 171-174, 1995 | 696 | 1995 |
| Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the … J Kreuter, P Ramge, V Petrov, S Hamm, SE Gelperina, B Engelhardt, ... Pharmaceutical research 20 (3), 409-416, 2003 | 577 | 2003 |
| Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles RN Alyautdin, VE Petrov, K Langer, A Berthold, DA Kharkevich, J Kreuter Pharmaceutical research 14 (3), 325-328, 1997 | 475 | 1997 |
| Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain K Michaelis, MM Hoffmann, S Dreis, E Herbert, RN Alyautdin, M Michaelis, ... Journal of Pharmacology and Experimental Therapeutics 317 (3), 1246-1253, 2006 | 397 | 2006 |
| Significant entry of tubocurarine into the brain of the rat is enabled by adsorption to polysorbate 80-coated polybutyl-cyanoacrylate nanoparticles: An in situ brain perfusion … RN Alyautdin, EB Tezikov, P Ramge, DA Kharkevich, DJ Begley, J Kreuter J. Microencapsul 15, 67-74, 2008 | 306* | 2008 |
| Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study RN Alyautdin, EB Tezikov, P Ramge, DA Kharkevich, DJ Begley, J Kreuter Journal of microencapsulation 15 (1), 67-74, 1998 | 306 | 1998 |
| Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly (butyl cyanoacrylate) nanoparticles R Alyautdin, D Gothier, V Petrov, D Kharkevich, J Kreuter European journal of pharmaceutics and biopharmaceutics 41 (1), 44-48, 1995 | 252 | 1995 |
| Nanoscale drug delivery systems and the blood–brain barrier R Alyautdin, I Khalin, MI Nafeeza, MH Haron, D Kuznetsov International journal of nanomedicine 9, 795, 2014 | 248 | 2014 |
| Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles J Kreuter, VE Petrov, DA Kharkevich, RN Alyautdin Journal of controlled release 49 (1), 81-87, 1997 | 244 | 1997 |
| Interaction of poly (butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro RN Alyaudtin, A Reichel, R Löbenberg, P Ramge, J Kreuter, DJ Begley Journal of drug targeting 9 (3), 209-221, 2001 | 237 | 2001 |
| Brain targeting of nerve growth factor using poly (butyl cyanoacrylate) nanoparticles KB Kurakhmaeva, IA Djindjikhashvili, VE Petrov, VU Balabanyan, ... Journal of drug targeting 17 (8), 564-574, 2009 | 230 | 2009 |
| Liposomes in topical ophthalmic drug delivery: an update R Agarwal, I Iezhitsa, P Agarwal, NA Abdul Nasir, N Razali, R Alyautdin, ... Drug delivery 23 (4), 1075-1091, 2016 | 136 | 2016 |
| Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs AA Kuznetsov, VI Filippov, RN Alyautdin, NL Torshina, OA Kuznetsov Journal of magnetism and magnetic materials 225 (1), 95-100, 2001 | 134 | 2001 |
| Фармакология РН Аляутдин, НГ Преферанский, НГ Преферанская Общество с ограниченной ответственностью Издательская группа ГЭОТАР-Медиа, 2016 | 133 | 2016 |
| Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof J Kreuter, K Langer, C Weber, R Alyautdin US Patent App. 10/476,653, 2004 | 95 | 2004 |
| Loading a nanoparticle with a drug, coating with polyoxyethylene glycol, sorbitan monosteare or monooleate, or monolaurate, or monopalmitate, administering to the mammal in … J Kreuter, RN Alyautdin, DA Karkevich, BA Sabel, ... US Patent 6,117,454, 2000 | 91* | 2000 |
| Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic … I Khalin, R Alyautdin, TW Wong, J Gnanou, G Kocherga, J Kreuter Drug delivery 23 (9), 3520-3528, 2016 | 90 | 2016 |
| The porphyrin–fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2+-magnetic isotope effect SM Rezayat, SVS Boushehri, B Salmanian, AH Omidvari, S Tarighat, ... European journal of medicinal chemistry 44 (4), 1554-1569, 2009 | 85 | 2009 |
| Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness I Khalin, R Alyautdin, G Kocherga, MA Bakar International journal of nanomedicine 10, 3245, 2015 | 52 | 2015 |
Nafeeza Mohd IsmailProfessor of PharmacologyVerified email at salam.uitm.edu.my
